Reportstack, provider of premium market research reports announces the addition of 'Restless Legs Syndrome - Pipeline Review, H1 2012' report to its offering.
Restless Legs Syndrome Pipeline Review, H1 2012, provides an overview of the Restless Legs Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Restless Legs Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Restless Legs Syndrome. 'Restless Legs Syndrome - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Restless Legs Syndrome.
- A review of the Restless Legs Syndrome products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Restless Legs Syndrome pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Restless Legs Syndrome.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Restless Legs Syndrome pipeline depth and focus of Restless Legs Syndrome therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64671/restless-legs-syndrome-pipeline-review-h1-2012.html
Wednesday, 4 April 2012
Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2012 - Latest Report
Reportstack, provider of premium market research reports announces the addition of 'Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2012' report to its offering.
The 'Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2012', provides an overview of the Keratoconjunctivitis sicca (Dry Eye) therapeutic pipeline. This report provides information on the therapeutic development for Keratoconjunctivitis sicca (Dry Eye), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Keratoconjunctivitis sicca (Dry Eye). 'Dry Eye Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Keratoconjunctivitis sicca (Dry Eye).
- A review of the Keratoconjunctivitis sicca (Dry Eye) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Keratoconjunctivitis sicca (Dry Eye) pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Keratoconjunctivitis sicca (Dry Eye).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Keratoconjunctivitis sicca pipeline depth and focus of Keratoconjunctivitis sicca (Dry Eye) therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64669/keratoconjunctivitis-sicca-dry-eye-pipeline-review-h1-2012.html
The 'Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2012', provides an overview of the Keratoconjunctivitis sicca (Dry Eye) therapeutic pipeline. This report provides information on the therapeutic development for Keratoconjunctivitis sicca (Dry Eye), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Keratoconjunctivitis sicca (Dry Eye). 'Dry Eye Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Keratoconjunctivitis sicca (Dry Eye).
- A review of the Keratoconjunctivitis sicca (Dry Eye) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Keratoconjunctivitis sicca (Dry Eye) pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Keratoconjunctivitis sicca (Dry Eye).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Keratoconjunctivitis sicca pipeline depth and focus of Keratoconjunctivitis sicca (Dry Eye) therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64669/keratoconjunctivitis-sicca-dry-eye-pipeline-review-h1-2012.html
Hepatitis A - Pipeline Review, H1 2012 - Latest Report
Reportstack, provider of premium market research reports announces the addition of 'Hepatitis A - Pipeline Review, H1 2012' report to its offering.
The 'Hepatitis A - Pipeline Review, H1 2012', provides an overview of the Hepatitis A therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis A, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hepatitis A. 'Hepatitis A - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Hepatitis A.
- A review of the Hepatitis A products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hepatitis A pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Hepatitis A.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Hepatitis A pipeline depth and focus of Hepatitis A therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64668/hepatitis-a-pipeline-review-h1-2012.html
The 'Hepatitis A - Pipeline Review, H1 2012', provides an overview of the Hepatitis A therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis A, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hepatitis A. 'Hepatitis A - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Hepatitis A.
- A review of the Hepatitis A products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hepatitis A pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Hepatitis A.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Hepatitis A pipeline depth and focus of Hepatitis A therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64668/hepatitis-a-pipeline-review-h1-2012.html
Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012 - Latest Report
Reportstack, provider of premium market research reports announces the addition of 'Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012' report to its offering.
The 'Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012', provides an overview of the Graft Versus Host Disease therapeutic pipeline. This report provides information on the therapeutic development for Graft Versus Host Disease (GVHD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Graft Versus Host Disease (GVHD). 'Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Graft Versus Host Disease (GVHD).
- A review of the Graft Versus Host Disease (GVHD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the GVHD pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Graft Versus Host Disease (GVHD).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Graft Versus Host pipeline depth and focus of Graft Versus Host Disease (GVHD) therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64666/graft-versus-host-disease-gvhd-pipeline-review-h1-2012.html
The 'Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012', provides an overview of the Graft Versus Host Disease therapeutic pipeline. This report provides information on the therapeutic development for Graft Versus Host Disease (GVHD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Graft Versus Host Disease (GVHD). 'Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Graft Versus Host Disease (GVHD).
- A review of the Graft Versus Host Disease (GVHD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the GVHD pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Graft Versus Host Disease (GVHD).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Graft Versus Host pipeline depth and focus of Graft Versus Host Disease (GVHD) therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64666/graft-versus-host-disease-gvhd-pipeline-review-h1-2012.html
Tuesday, 3 April 2012
Consumer Trends in the Beer, Cider & Pre-mixed Spirits Market in Russia, 2011 - Latest Report
Reportstack, provider of premium market research reports announces the addition of 'Consumer Trends in the Beer, Cider & Pre-mixed Spirits Market in Russia, 2011' report to its offering.
Marketers in the Beer, Cider & Pre-mixed Spirits market in Russia face a major challenge. Understanding market size and segmentation is valuable, but the keys to effective targeting is knowing just how valuable specific consumer groups are, and being able to quantify the impact of consumer trends.
This report solves these problems by providing integrated survey-based data on consumer trends, consumer groups and market data which show exactly the size of consumer groups, how much of the Pre-mixed Spirits, Cider & Beer market in Russia they account for and which consumer trends drive their behaviour.
Scope
Consumers' uptake of products and the influence of consumer trends are fundamental causes of change in markets - making knowing what these trends are and the extent of their influence crucial.
The survey-based data provided in this report examines over 20 consumer trends that affect the market and examines the share of sales across 26 consumer groups - providing through the data a detailed insight into exactly who the consumer is and just how much impact the latest consumer trends are having.
Reasons to Buy
The data provided allows marketers to track consumer behaviour through to its actual value impact on a product market. Unique in the market, this provides readers with a highly detailed data analysis of the market allowing marketing tactics and strategy to be updated in line with the very latest consumer behaviours.
Key Highlights
Consumer survey data for the following specific categories: Lager, Beer and Ale, Flavoured Alcoholic Beverages, Cider, and Low Alcohol Beer & Lager.
Detailed consumer segmentation based on survey data covering over 26 consumer groups, 20 consumer trends and consumption frequency for each product category.
Brand and private label penetration among consumers in 2011 as tracked by the survey.
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64051/consumer-trends-in-the-beer-cider-pre-mixed-spirits-market-in-russia-2011.html
Marketers in the Beer, Cider & Pre-mixed Spirits market in Russia face a major challenge. Understanding market size and segmentation is valuable, but the keys to effective targeting is knowing just how valuable specific consumer groups are, and being able to quantify the impact of consumer trends.
This report solves these problems by providing integrated survey-based data on consumer trends, consumer groups and market data which show exactly the size of consumer groups, how much of the Pre-mixed Spirits, Cider & Beer market in Russia they account for and which consumer trends drive their behaviour.
Scope
Consumers' uptake of products and the influence of consumer trends are fundamental causes of change in markets - making knowing what these trends are and the extent of their influence crucial.
The survey-based data provided in this report examines over 20 consumer trends that affect the market and examines the share of sales across 26 consumer groups - providing through the data a detailed insight into exactly who the consumer is and just how much impact the latest consumer trends are having.
Reasons to Buy
The data provided allows marketers to track consumer behaviour through to its actual value impact on a product market. Unique in the market, this provides readers with a highly detailed data analysis of the market allowing marketing tactics and strategy to be updated in line with the very latest consumer behaviours.
Key Highlights
Consumer survey data for the following specific categories: Lager, Beer and Ale, Flavoured Alcoholic Beverages, Cider, and Low Alcohol Beer & Lager.
Detailed consumer segmentation based on survey data covering over 26 consumer groups, 20 consumer trends and consumption frequency for each product category.
Brand and private label penetration among consumers in 2011 as tracked by the survey.
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64051/consumer-trends-in-the-beer-cider-pre-mixed-spirits-market-in-russia-2011.html
Consumer Trends in the Beer, Cider & Pre-mixed Spirits Market in China, 2011 - Latest Report
Reportstack, provider of premium market research reports announces the addition of 'Consumer Trends in the Beer, Cider & Pre-mixed Spirits Market in China, 2011' report to its offering.
Marketers in the Beer, Cider & Pre-mixed Spirits market in China face a major challenge. Understanding market size and segmentation is valuable, but the keys to effective targeting is knowing just how valuable specific consumer groups are, and being able to quantify the impact of consumer trends.
This report solves these problems by providing integrated survey-based data on consumer trends, consumer groups and market data which show exactly the size of consumer groups, how much of the Pre-mixed Spirits, Cider & Beer market in China they account for and which consumer trends drive their behaviour.
Scope
Consumers' uptake of products and the influence of consumer trends are fundamental causes of change in markets - making knowing what these trends are and the extent of their influence crucial.
The survey-based data provided in this report examines over 20 consumer trends that affect the market and examines the share of sales across 26 consumer groups - providing through the data a detailed insight into exactly who the consumer is and just how much impact the latest consumer trends are having.
Reasons to Buy
The data provided allows marketers to track consumer behaviour through to its actual value impact on a product market. Unique in the market, this provides readers with a highly detailed data analysis of the market allowing marketing tactics and strategy to be updated in line with the very latest consumer behaviours.
Key Highlights
Consumer survey data for the following specific categories: Lager, Beer and Ale, Flavoured Alcoholic Beverages, Cider, and Low Alcohol Beer & Lager.
Detailed consumer segmentation based on survey data covering over 26 consumer groups, 20 consumer trends and consumption frequency for each product category.
Brand and private label penetration among consumers in 2011 as tracked by the survey.
Unique retailer choice and switching data as tracked by the survey are provided at the product category level for 2011
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64050/consumer-trends-in-the-beer-cider-pre-mixed-spirits-market-in-china-2011.html
Marketers in the Beer, Cider & Pre-mixed Spirits market in China face a major challenge. Understanding market size and segmentation is valuable, but the keys to effective targeting is knowing just how valuable specific consumer groups are, and being able to quantify the impact of consumer trends.
This report solves these problems by providing integrated survey-based data on consumer trends, consumer groups and market data which show exactly the size of consumer groups, how much of the Pre-mixed Spirits, Cider & Beer market in China they account for and which consumer trends drive their behaviour.
Scope
Consumers' uptake of products and the influence of consumer trends are fundamental causes of change in markets - making knowing what these trends are and the extent of their influence crucial.
The survey-based data provided in this report examines over 20 consumer trends that affect the market and examines the share of sales across 26 consumer groups - providing through the data a detailed insight into exactly who the consumer is and just how much impact the latest consumer trends are having.
Reasons to Buy
The data provided allows marketers to track consumer behaviour through to its actual value impact on a product market. Unique in the market, this provides readers with a highly detailed data analysis of the market allowing marketing tactics and strategy to be updated in line with the very latest consumer behaviours.
Key Highlights
Consumer survey data for the following specific categories: Lager, Beer and Ale, Flavoured Alcoholic Beverages, Cider, and Low Alcohol Beer & Lager.
Detailed consumer segmentation based on survey data covering over 26 consumer groups, 20 consumer trends and consumption frequency for each product category.
Brand and private label penetration among consumers in 2011 as tracked by the survey.
Unique retailer choice and switching data as tracked by the survey are provided at the product category level for 2011
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64050/consumer-trends-in-the-beer-cider-pre-mixed-spirits-market-in-china-2011.html
Consumer Trends in the Beer, Cider & Pre-mixed Spirits Market in Brazil, 2011 - Latest Report
Reportstack, provider of premium market research reports announces the addition of 'Consumer Trends in the Beer, Cider & Pre-mixed Spirits Market in Brazil, 2011' report to its offering.
Marketers in the Beer, Cider & Pre-mixed Spirits market in Brazil face a major challenge. Understanding market size and segmentation is valuable, but the keys to effective targeting is knowing just how valuable specific consumer groups are, and being able to quantify the impact of consumer trends.
This report solves these problems by providing integrated survey-based data on consumer trends, consumer groups and market data which show exactly the size of consumer groups, how much of the Beer, Cider & Pre-mixed Spirits market in Brazil they account for and which consumer trends drive their behaviour.
Scope
Consumers' uptake of products and the influence of consumer trends are fundamental causes of change in markets - making knowing what these trends are and the extent of their influence crucial.
The survey-based data provided in this report examines over 20 consumer trends that affect the market and examines the share of sales across 26 consumer groups - providing through the data a detailed insight into exactly who the consumer is and just how much impact the latest consumer trends are having.
Reasons to Buy
The data provided allows marketers to track consumer behaviour through to its actual value impact on a product market. Unique in the market, this provides readers with a highly detailed data analysis of the market allowing marketing tactics and strategy to be updated in line with the very latest consumer behaviours.
Key Highlights
Consumer survey data for the following specific categories: Lager, Beer and Ale, Flavoured Alcoholic Beverages, Cider, and Low Alcohol Beer & Lager.
Detailed consumer segmentation based on survey data covering over 26 consumer groups, 20 consumer trends and consumption frequency for each product category.
Brand and private label penetration among consumers in 2011 as tracked by the survey.
Unique retailer choice and switching data as tracked by the survey are provided at the product category level for 2011
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64049/consumer-trends-in-the-beer-cider-pre-mixed-spirits-market-in-brazil-2011.html
Marketers in the Beer, Cider & Pre-mixed Spirits market in Brazil face a major challenge. Understanding market size and segmentation is valuable, but the keys to effective targeting is knowing just how valuable specific consumer groups are, and being able to quantify the impact of consumer trends.
This report solves these problems by providing integrated survey-based data on consumer trends, consumer groups and market data which show exactly the size of consumer groups, how much of the Beer, Cider & Pre-mixed Spirits market in Brazil they account for and which consumer trends drive their behaviour.
Scope
Consumers' uptake of products and the influence of consumer trends are fundamental causes of change in markets - making knowing what these trends are and the extent of their influence crucial.
The survey-based data provided in this report examines over 20 consumer trends that affect the market and examines the share of sales across 26 consumer groups - providing through the data a detailed insight into exactly who the consumer is and just how much impact the latest consumer trends are having.
Reasons to Buy
The data provided allows marketers to track consumer behaviour through to its actual value impact on a product market. Unique in the market, this provides readers with a highly detailed data analysis of the market allowing marketing tactics and strategy to be updated in line with the very latest consumer behaviours.
Key Highlights
Consumer survey data for the following specific categories: Lager, Beer and Ale, Flavoured Alcoholic Beverages, Cider, and Low Alcohol Beer & Lager.
Detailed consumer segmentation based on survey data covering over 26 consumer groups, 20 consumer trends and consumption frequency for each product category.
Brand and private label penetration among consumers in 2011 as tracked by the survey.
Unique retailer choice and switching data as tracked by the survey are provided at the product category level for 2011
To view the detailed table of contents kindly visit: http://www.reportstack.com/product/64049/consumer-trends-in-the-beer-cider-pre-mixed-spirits-market-in-brazil-2011.html
Subscribe to:
Posts (Atom)